Pharma News

IQVIA Signal Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections

IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections

FDA & Regulatory Intelligence, Pharma Market Case Studies, Pharma News / Leave a Comment

IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections | Witfire Elite View Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market Case Study Witfire Elite View IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections A data-rich pharma case study on how IQVIA’s early […]

IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections Read More »

FDA’s Digital Liver Break How AI Toxicology Could Change Drug Development Before Phase I

FDA’s Digital Liver Break: How AI Toxicology Could Change Drug Development Before Phase I

FDA & Regulatory Intelligence, Pharma Market Case Studies, Pharma News / Leave a Comment

FDA’s Digital Liver Break: How AI Toxicology Could Change Drug Development Before Phase I | Witfire Elite View Witfire Elite FDA & Regulatory Case Studies Strategy Long Read FDA & Regulatory Intelligence Witfire Elite View FDA’s Digital Liver Break How AI Toxicology Could Change Drug Development Before Phase I FDA accepted the first in silico

FDA’s Digital Liver Break: How AI Toxicology Could Change Drug Development Before Phase I Read More »

The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China

The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China

Pharma Market Case Studies, Pharma News / Leave a Comment

The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China | Witfire Elite View Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market Case Study Witfire Elite View The China Biotech Pipeline Grab How Big Pharma Started Buying Innovation From China A data-heavy pharma case study on how Pfizer, BMS,

The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China Read More »

The Pharma Tariff War How US Drug Pricing Pressure Is Forcing Big Pharma to Rewrite Global Strategy

The Pharma Tariff War: How US Drug Pricing Pressure Is Forcing Big Pharma to Rewrite Global Strategy

Pharma News, Stock Market / Leave a Comment

The Pharma Tariff War: How US Drug Pricing Pressure Is Forcing Big Pharma to Rewrite Global Strategy | Witfire Elite View Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market Case Study Witfire Elite View The Pharma Tariff War How US Drug Pricing Pressure Is Forcing Big Pharma to Rewrite Global Strategy A

The Pharma Tariff War: How US Drug Pricing Pressure Is Forcing Big Pharma to Rewrite Global Strategy Read More »

GLP-1 Market Becomes Pharma’s Biggest Business Battle

GLP-1 Market Becomes Pharma’s Biggest Business Battle

Pharma News / Leave a Comment

GLP-1 Market: The obesity and diabetes drug race is becoming one of the biggest business stories in global pharma. Reuters reported that analysts now estimate global obesity drug sales around USD 105 billion by 2030, lower than earlier USD 130 billion forecasts because of expected price pressure and changing usage patterns. IQVIA’s obesity outlook is

GLP-1 Market Becomes Pharma’s Biggest Business Battle Read More »

War Heat Reaches Pharma as Oil, Air Cargo and Cold-Chain Drugs Face Pressure

War Heat Reaches Pharma as Oil, Air Cargo and Cold-Chain Drugs Face Pressure

Pharma News / Leave a Comment

The Middle East conflict is now moving directly into pharma boardroom risk. Oil-market stress has intensified, with Vitol’s Bahrain chief warning that the market may still be underpricing the impact of disrupted Middle East supply, including a reported removal of nearly 14 million barrels per day from normal supply flows. Crude prices reportedly spiked as

War Heat Reaches Pharma as Oil, Air Cargo and Cold-Chain Drugs Face Pressure Read More »

Data That Shows Why Pharma Business Is Becoming Bigger and More Serious

Data That Shows Why Pharma Business Is Becoming Bigger and More Serious

Pharma News / Leave a Comment

The pharmaceutical business is no longer a small product-driven market. It is becoming one of the most strategic global industries. IQVIA has projected that global medicine spending may reach nearly USD 2.3 trillion by 2028. This growth is not only due to price increases. It is also linked with higher patient access, stronger use of

Data That Shows Why Pharma Business Is Becoming Bigger and More Serious Read More »